Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

<p>Abstract</p> <p>Background</p> <p>Ascites may affect the progression of ovarian cancer (OC). In particular, soluble factors present in OC ascites can create a protective environment for tumor cells that promote <it>de novo</it> resistance to drug- and dea...

Full description

Bibliographic Details
Main Authors: Goncharenko-Khaider Nadzeya, Matte Isabelle, Lane Denis, Rancourt Claudine, Piché Alain
Format: Article
Language:English
Published: BMC 2012-11-01
Series:Molecular Cancer
Subjects:
Online Access:http://www.molecular-cancer.com/content/11/1/84
_version_ 1811251240499150848
author Goncharenko-Khaider Nadzeya
Matte Isabelle
Lane Denis
Rancourt Claudine
Piché Alain
author_facet Goncharenko-Khaider Nadzeya
Matte Isabelle
Lane Denis
Rancourt Claudine
Piché Alain
author_sort Goncharenko-Khaider Nadzeya
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Ascites may affect the progression of ovarian cancer (OC). In particular, soluble factors present in OC ascites can create a protective environment for tumor cells that promote <it>de novo</it> resistance to drug- and death receptor-induced apoptosis. However, the underlying molecular mechanisms responsible for ascites-induced drug resistance are not well characterized.</p> <p>Methods</p> <p>Using human OC cell lines and tissues microarrays of human OC biopsies, we assessed the mechanism by which OC ascites increase Mcl-1 expression using Western blots, chemical inhibitors of ERK and small-inhibitory RNA treatments.</p> <p>Results</p> <p>In the present study, we found that both Mcl-1 mRNA and protein levels were upregulated within 2 h upon treatment of OC cells with ascites obtained from women with advanced OC. In contrast, the expression of other Bcl-2 family antiapoptotic members such as Bcl-2 and Bcl-X<sub>L</sub> was not affected by ascites. An increase of Mcl-1 expression was consistently observed across different ascites from women with advanced serous OC. The knockdown of Mcl-1 significantly blocked ascites-induced Mcl-1 upregulation and ascites-mediated inhibition of TRAIL-induced apoptosis. Ascites induced a rapid phosphorylation of ERK1/2 and Elk-1 transcription factor. Furthermore, we found that ERK1/2 inhibition or Elk-1 knockdown was sufficient to block ascites-induced Mcl-1 expression. In high grade serous OC, we found a positive correlation between phosphorylated ERK1/2 and Mcl-1 expression.</p> <p>Conclusions</p> <p>These results indicate that ascites-induced ERK1/2/Elk-1 signaling is critical for Mcl-1 expression and for the ascites-mediated attenuation of TRAIL-induced apoptosis. The ERK1/2/Elk-1/Mcl-1 pathway represents a novel mechanism by which ascites induce <it>de novo</it> TRAIL resistance in OC cells.</p>
first_indexed 2024-04-12T16:16:50Z
format Article
id doaj.art-c668fb4891a94057b5e1c8f2bc52b9a3
institution Directory Open Access Journal
issn 1476-4598
language English
last_indexed 2024-04-12T16:16:50Z
publishDate 2012-11-01
publisher BMC
record_format Article
series Molecular Cancer
spelling doaj.art-c668fb4891a94057b5e1c8f2bc52b9a32022-12-22T03:25:42ZengBMCMolecular Cancer1476-45982012-11-011118410.1186/1476-4598-11-84Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosisGoncharenko-Khaider NadzeyaMatte IsabelleLane DenisRancourt ClaudinePiché Alain<p>Abstract</p> <p>Background</p> <p>Ascites may affect the progression of ovarian cancer (OC). In particular, soluble factors present in OC ascites can create a protective environment for tumor cells that promote <it>de novo</it> resistance to drug- and death receptor-induced apoptosis. However, the underlying molecular mechanisms responsible for ascites-induced drug resistance are not well characterized.</p> <p>Methods</p> <p>Using human OC cell lines and tissues microarrays of human OC biopsies, we assessed the mechanism by which OC ascites increase Mcl-1 expression using Western blots, chemical inhibitors of ERK and small-inhibitory RNA treatments.</p> <p>Results</p> <p>In the present study, we found that both Mcl-1 mRNA and protein levels were upregulated within 2 h upon treatment of OC cells with ascites obtained from women with advanced OC. In contrast, the expression of other Bcl-2 family antiapoptotic members such as Bcl-2 and Bcl-X<sub>L</sub> was not affected by ascites. An increase of Mcl-1 expression was consistently observed across different ascites from women with advanced serous OC. The knockdown of Mcl-1 significantly blocked ascites-induced Mcl-1 upregulation and ascites-mediated inhibition of TRAIL-induced apoptosis. Ascites induced a rapid phosphorylation of ERK1/2 and Elk-1 transcription factor. Furthermore, we found that ERK1/2 inhibition or Elk-1 knockdown was sufficient to block ascites-induced Mcl-1 expression. In high grade serous OC, we found a positive correlation between phosphorylated ERK1/2 and Mcl-1 expression.</p> <p>Conclusions</p> <p>These results indicate that ascites-induced ERK1/2/Elk-1 signaling is critical for Mcl-1 expression and for the ascites-mediated attenuation of TRAIL-induced apoptosis. The ERK1/2/Elk-1/Mcl-1 pathway represents a novel mechanism by which ascites induce <it>de novo</it> TRAIL resistance in OC cells.</p>http://www.molecular-cancer.com/content/11/1/84Ovarian cancerResistanceMcl-1ERK1/2TRAILElk-1
spellingShingle Goncharenko-Khaider Nadzeya
Matte Isabelle
Lane Denis
Rancourt Claudine
Piché Alain
Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
Molecular Cancer
Ovarian cancer
Resistance
Mcl-1
ERK1/2
TRAIL
Elk-1
title Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
title_full Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
title_fullStr Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
title_full_unstemmed Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
title_short Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis
title_sort ovarian cancer ascites increase mcl 1 expression in tumor cells through erk1 2 elk 1 signaling to attenuate trail induced apoptosis
topic Ovarian cancer
Resistance
Mcl-1
ERK1/2
TRAIL
Elk-1
url http://www.molecular-cancer.com/content/11/1/84
work_keys_str_mv AT goncharenkokhaidernadzeya ovariancancerascitesincreasemcl1expressionintumorcellsthrougherk12elk1signalingtoattenuatetrailinducedapoptosis
AT matteisabelle ovariancancerascitesincreasemcl1expressionintumorcellsthrougherk12elk1signalingtoattenuatetrailinducedapoptosis
AT lanedenis ovariancancerascitesincreasemcl1expressionintumorcellsthrougherk12elk1signalingtoattenuatetrailinducedapoptosis
AT rancourtclaudine ovariancancerascitesincreasemcl1expressionintumorcellsthrougherk12elk1signalingtoattenuatetrailinducedapoptosis
AT pichealain ovariancancerascitesincreasemcl1expressionintumorcellsthrougherk12elk1signalingtoattenuatetrailinducedapoptosis